Copy to clipboard 
Implanet signed a distribution agreement for its JAZZ® range in China and a technology partnership with Sanyou Medical.
In accordance with the partnership plan communicated in June 2022 and following the success of the capital increase carried out with the support of Sanyou Medical, the collaboration between the two groups is taking shape with the signature of two agreements, the first commercial and the second technological.
The commercial agreement covers the distribution of Implanet’s JAZZ platform. The registration of Implanet’s proprietary JAZZ range with Chinese health authorities is underway.
The technological alliance between Implanet and Sanyou Medical will enable the synergy of the two groups’ technological know-how and R&D in order to accelerate their product innovation policy. This partnership aims to jointly develop a brand-new European hybrid fixation system range, incorporating the very latest developments and innovations in the field of spine surgery.
Ludovic LASTENNET, Implanet’s Chief Executive Officer, said, “In continuation of the capital increase we completed with the support of Sanyou Medical, we are proud to further strengthen the strategic partnership between our two groups, this time on a commercial and technological level. The distribution agreement we signed will enable us to market our entire JAZZ range in China, the world’s largest market, and for which the regulatory files are already being initiated with the Chinese health authorities. On the technological side, this agreement enables us to leverage our respective expertise by jointly developing a new and innovative range of fixation systems for the Western markets. Lastly, the reconciliation we are making today with one of the largest manufacturers of medical devices in China will give us rapid access to leading technologies and know-how in the field of spinal surgery.”
Source: Implanet
Implanet signed a distribution agreement for its JAZZ® range in China and a technology partnership with Sanyou Medical.
In accordance with the partnership plan communicated in June 2022 and following the success of the capital increase carried out with the support of Sanyou Medical, the collaboration between the two groups is taking shape...
Implanet signed a distribution agreement for its JAZZ® range in China and a technology partnership with Sanyou Medical.
In accordance with the partnership plan communicated in June 2022 and following the success of the capital increase carried out with the support of Sanyou Medical, the collaboration between the two groups is taking shape with the signature of two agreements, the first commercial and the second technological.
The commercial agreement covers the distribution of Implanet’s JAZZ platform. The registration of Implanet’s proprietary JAZZ range with Chinese health authorities is underway.
The technological alliance between Implanet and Sanyou Medical will enable the synergy of the two groups’ technological know-how and R&D in order to accelerate their product innovation policy. This partnership aims to jointly develop a brand-new European hybrid fixation system range, incorporating the very latest developments and innovations in the field of spine surgery.
Ludovic LASTENNET, Implanet’s Chief Executive Officer, said, “In continuation of the capital increase we completed with the support of Sanyou Medical, we are proud to further strengthen the strategic partnership between our two groups, this time on a commercial and technological level. The distribution agreement we signed will enable us to market our entire JAZZ range in China, the world’s largest market, and for which the regulatory files are already being initiated with the Chinese health authorities. On the technological side, this agreement enables us to leverage our respective expertise by jointly developing a new and innovative range of fixation systems for the Western markets. Lastly, the reconciliation we are making today with one of the largest manufacturers of medical devices in China will give us rapid access to leading technologies and know-how in the field of spinal surgery.”
Source: Implanet
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
